December - 2011
| Previous Next | Showing Journal 2 of 17 |
Effect of intravenous ²-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trialProf Fang Gao Smith, Prof Gavin D Perkins, Simon Gates, Duncan Young et al The Lancet, 2011, Published on line ahead of print This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
December |
Previous Comments
No Comments yet.
Comment
With inhaled beta-agonists in Acute Lung Injury falling from favour after a recent randomised controlled trial, the BALTI investigators have released their study into intravenous salbutamol in ARDS. Sadly, this too has come up short of expectations, with the trial halted early due to...